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The Glasgow Aneurysm Score does not predict
mortality after open abdominal aortic aneurysm
in the era of endovascular aneurysm repair
Benjamin Oliver Patterson, BSc, MRCS, Alan Karthikesalingam, MA, MRCS,
Robert J. Hinchliffe, MD, MRCS, Ian M. Loftus, MD, FRCS, Matt M. Thompson, MD, FRCS, and
Peter J. E. Holt, PhD, FRCS, London, United Kingdom
Objective: Endovascular aneurysm repair (EVAR) has reduced early adverse outcomes from abdominal aortic aneurysm
(AAA) repair. Preferential use of EVAR may have altered the profile of patients who undergo open repair. The validity
of scoring systems such as the Glasgow Aneurysm Score (GAS), devised when open surgery was the only treatment,
required reappraisal.
Methods: Patients were identified from a database of patients undergoing elective infrarenal aneurysm repair at seven
United Kingdom centers, and the GAS was calculated for each patient. Discrimination and calibration were calculated to
determine the performance of the model in this setting using the C statistic, tertile analysis, and the 2 test. Univariate
analysis was performed to determine if a new iteration of the GAS could be produced.
Results:We identified 330 patients who met the inclusion criteria. There were 18 deaths<30 days of surgery (5.4%). The
average (standard deviation) GAS was 78.6 (8.8) for the survivors and 81.9 (10.4) for nonsurvivors (P  .122). The C
statistic was 0.625 (95% confidence interval, 0.481-0.769; P  .75) suggesting a discriminatory ability not much better
than chance alone. Despite this, calibration of the model was good. There was no significant difference in the
comorbidities of either group, so no recalibration of the GAS could be performed.
Conclusion: The GAS did not discriminate between survivors and nonsurvivors after open AAA repair in this cohort. In
the era of EVAR, it is possible that the GAS does not predict the outcome of open AAA repair. An alternative explanation
is that patients with risk factors for poor outcomes from EVAR, such as adverse AAAmorphology, are being selected out
for open repair. ( J Vasc Surg 2011;54:353-7.)
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pMortality after the rupture of abdominal aortic aneu-
rysms (AAAs) has remained unchanged over several de-
cades.1-3 Early detection and elective repair is the most
effective way of reducing aneurysm-related death at pres-
ent. The risk associated with such procedures must be
carefully considered if the procedure is to be in the best
interest of the patient.
A recent systematic review of risk prediction systems for
AAA repair suggested that although some systems showed
promise, none of the available methods were ideal, and
most had significant drawbacks.4 The most useful score for
predicting the results of open AAA repair was the Glasgow
Aneurysm Score (GAS). This was first devised in 1994 and
was validated using a number of patient cohorts, with
varying degrees of success.
Endovascular aneurysm repair (EVAR) has reduced the
early mortality and morbidity associated with AAA repair.
The widespread availability, and in some centers preferen-
tial use, of EVAR may have altered the profile of patients
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hus, in the endovascular era, the validity of scoring sys-
ems such as the GAS, devised for all patients with operable
AA before the development of EVAR, requires reap-
raisal.
The aim of this study was to quantify the discriminative
bility of theGAS using contemporarymulticenter UK data
nd attempt to recalibrate the weighting of the various
omponents.
ETHODS
Patients. Patients were identified from a database
ompiled for a parallel project using data from seven vascu-
ar centers in the UK encompassing the period 2005 to
007. The six centers were St. George’s Vascular Institute
London), St. Thomas’ Hospital (London), Frimley Park
ospital, Hull Royal Infirmary, Queen’s Medical Center
Nottingham), Bristol Royal Infirmary, and Southampton
eneral Hospital. Institutional review board permission
as previously obtained for a broader project of which this
ork was a component.
The inclusion criterion was elective open repair of
nfrarenal AAAs. Exclusion criteria included emergency
dmissions (mainly ruptured aneurysms), thoracoabdomi-
al aneurysms, hybrid revascularization and aneurysm re-
air procedures, and any other non-AAA repair. For the
urposes of these analyses, mortality was defined as death
30 days of the primary procedure.
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August 2011354 Patterson et alTheGASwas calculated for each patient identified from
the database. The values for each component of the score
were as described in the original study.5 The GAS com-
prised patient age,  7 for cardiovascular disease,  10 for
cerebrovascular disease, and  14 for renal disease. We
defined renal failure as an estimated glomerular filtration
rate (eGRF) of34 mL/min/1.73 m,2 which equates to a
creatinine level 180 mg/dL. The eGFR was calculated
using the Modification of Diet in Renal Disease Study
Group equation.6 Cardiovascular disease was defined as a
history of angina, myocardial infarction, percutaneous cor-
onary intervention, cardiac surgery or an abnormal electro-
cardiogram. Cerebrovascular disease was defined as any
history of a stroke or transient ischemic attack.
Statistical analysis. Patients undergoing elective
open infrarenal aneurysm repair were identified by interro-
gation of the database. A spreadsheet was constructed using
Excel 2003 (Microsoft Corpmond, Wash). The GAS was
calculated from the component variables using a formula
written into the spreadsheet. All further statistical analysis
was performed using SPSS 16 software (SPSS Inc, Chicago,
Ill).
The measure of discrimination used was the area under
a receiver-operator characteristic (ROC) curve (referred to
here as the “C statistic”).6 Discrimination is defined as the
ability of a test to identify high risk in individual patients. A
ROC curve uses a visual representation of the sensitivity-
specificity balance to determine the ability of a test to
predict the outcome of a dichotomous event. Sensitivity is
plotted against (1 – specificity) over the range of values for
the test being investigated. An ideal test would produce a
curve that would be nearly vertical, turning sharply to the
horizontal near to point (0,1) with a C statistic close to 1. A
diagonal line from point (0,0) to (1,1) suggests the test has
a predictive power equivalent to chance alone with a C
statistic of 0.5. The C statistic derived from the curve
produces a value between 0.5 and 1. This represents the
probability that the test will predict an outcome in compar-
ison with random chance. Values 0.70 denote poor dis-
criminatory power, and values 0.80 indicate reliable ac-
curacy. A statistical test of significance produces a P value
associated with the C statistic. This tests the null hypothesis
that the C statistic will equal 0.5 and that the GAS is
nondiscriminatory.
The point of the ROC closest to the upper left of the
axis represents the point where the score achieves the best
balance of sensitivity and specificity. It is at this point that a
cutoff point can be defined. For example, when considering
scores to predict the result of AAA repair, this would be the
value of the score that divides patients into high-risk and
low-risk subgroups.
Two methods were used to control for missing values.
For categoric variables, such as the presence or absence of
cerebrovascular disease, we assumed that there was no
cerebrovascular disease if these data were not present. For
numeric data, such serum electrolyte levels, the mean value
from all samples was entered into the spreadsheet. More
complex approaches to missing data were not used, such as fultiple regression or value imputation. Confidence inter-
als (CIs) were calculated using the nonparametric asymp-
otic method.
Because theGAS does not produce predictions of death
n an individual basis, expected deaths were calculated
sing the Finnvasc validation cohort study cutoff points for
ow (69  2%), moderate (69-77  4%), and high
77  9%) risk of death.7 Numbers of expected deaths
ere calculated in each tertile group based on these per-
entage values. This study was selected as a reference be-
ause it is one of the largest validation cohorts, and many
ther studies only give one cutoff value defining “high-
isk” and “low-risk” groups, which is less helpful. Observed
eaths were summed for each tertile. This was an assess-
ent of calibration of the GAS in this cohort, which can be
efined as the accuracy of numerical risk predictions. The
2 test was used to compare the observed and expected
requency of mortality in low-, moderate-, and high-risk
roups.
Univariate analysis was performed on each of the four
omponents of the GAS to determine if they were predic-
ive of death. Dichotomous data were analyzed using the 2
est or Fisher exact test where there were subgroups of
ewer than five patients; parametric continuous data were
nalyzed using the t test, and nonparametric continuous
ata were analyzed using the Mann-Whitney U test. Thus,
2 test was used for cardiac disease and cerebrovascular
isease, the Fisher exact test was used for renal function,
nd the t test was used for age.
ESULTS
The database included 1243 patients who underwent
pen or EVAR repair of AAAs consecutively between 2005
nd 2007. We identified 405 patients who underwent open
epair, of which six were excluded because they underwent
horacoabdominal aneurysm repair, three had undergone
liac aneurysm repair, three had suprarenal repair, and 48
ad juxtarenal aneurysms. Mortality data were not available
able I. Components of the Glasgow Aneurysm Score
ith subsequent univariate analysis
ariablea Survivors Nonsurvivors P
ge mean (range) y 74.4 (50-94) 77 (58-87) .108b
ender, % .062c
Male 85.3 100
Female 14.7 0
lasgow score,
mean (SD) 78.6 (10.4) 81.9 (8.792) .122d
ardiac disease 83 (26.6) 5 (27.7) .619d
erebrovascular
disease 55 (21.7) 4 (22.2) .416d
enal failure 13 (4) 1 (5.6) .551c
Data are presented as number (%) unless otherwise indicated.
Independent samples t test.
Fisher exact test.
2 test.or 15 patients. After exclusion criteria were applied, 330
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Volume 54, Number 2 Patterson et al 355patients (27% of the entire cohort) with open infrarenal
AAA repair were eligible for our study. The mean age was
74.4 years and 85%weremale. There were 18 (5.4%) deaths
30 days.
Patient characteristics are summarized dividing the popu-
lation into survivors and nonsurvivors (Table I). The average
(standard deviation)GASwas 78.6 (8.8) in survivors and 81.9
(10.4) in nonsurvivors. Independent sample t test found no
significant difference between these values (95%CI –0.899 to
7.570; P  .122 [df 328]). An ROC analysis produced an
AUC of 0.625 (95% CI, 0.481-0.769; P  .75). This sug-
Fig 1. Receiver-operator characteristic curve displays t
predict 30-day mortality. The straight diagonal line is th
Table II. Results of the area under the curve (AUC)
calculation analysis from the receiver-operator
characteristic curve shown in Fig 1a
Asymptotic
AUC SE P 95% CI
0.625 0.073 .75 0.481-0.769
CI, Confidence interval; SE, standard error.
aThe AUC value of 0.625 suggests the Glasgow Aneurysm Score is poorly
discriminatory when used to predict the 30-day mortality of patients under-
going open aneurysm repair.gested a discriminatory ability not much better than chance 5lone, because the P value was nonsignificant and the 95% CI
rossed 0.5 for the AUC (Fig 1, Table II).
Observed and expected deaths were calculated for each
ertile, and the significance of any discrepancy in frequency
as analyzed for significance using the 2 test (Fig 2). Ob-
erved and expected mortality showed a good agreement,
ignifying that the GAS was calibrated well to the data set for
ow-risk patients of GAS  69 (40 patients, 5% observed vs
.4% expected mortality, 2  1.837 [df  1], P  .175),
edium-risk patients with GAS 69 to 77 (111 patients, 1.8%
bserved vs 4.1% expected mortality, 2 1.451 [df 1], P
228), and the high-risk group with GAS 77 (179 patients,
.8% observed vs 9.3 expected, 2 .447 [df 1], P .504).
Univariate analysis was undertaken to determine if it
ould be possible to reassign the weighting of the compo-
ents of the GAS usingmultivariate regression analysis (Table
). Neither age (P  .108), cardiac disease (P  .619),
erebrovascular disease (P  .416), nor renal failure (P 
551) were independently predictive of death. Only gender
pproached significance because all patients who died were
ale (2; P .062).
ISCUSSION
The GAS was developed in 1994 using a population of
scriminative ability of the Glasgow Aneurysm Score to
rence line.he di00 patients undergoing AAA repair between 1980 and
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August 2011356 Patterson et al1990. Logistic regression was used to identify factors that
predicted death immediately postoperatively. Preoperative
shock, myocardial dysfunction, renal impairment, and cere-
brovascular disease were identified as significant predictors
of death using univariate analysis and in the subsequent
multivariate model.5 The score was validated successfully
by the same group shortly afterward, confirming the accu-
racy of this method of predicting the immediate outcome
of elective and emergency open AAA repair.8
Further work in 2003 validated the GAS using data
from 403 patients operated on in a single hospital and then
again on a separate occasion using the Finnvasc national
database. The AUC for immediate mortality was 0.80 (95%
CI, 0.71-0.90) in the smaller group. Patient age (P 
.001), cerebrovascular disease (P .040), renal failure (P
.001), and GAS itself (P .001) were significant predictors
of death in these patients. The mean GAS was 73.1 (inter-
quartile range [IQR], 65.2-79.6). In the survivor group,
the GAS was 72.8 (IQR, 64.9-79.4) compared with the
nonsurvival group mean of 86.0 (IQR, 76.4-89.6).9
Analysis of the Finnvasc registry demonstrated that the
predictive power for mortality was lower than previously
suggested with an AUC of only 0.668 (P .0001). In this
instance, cardiac disease, renal disease and patient age were
significantly associated with postoperative mortality (P 
.05). The average (SD) GAS was 72 (10) in the survivor
group and 77 (10.4) in the nonsurvivor group. This is the
only study published that firmly suggested that the GAS is
inaccurate in this context.7
Since then, Dutch and UK investigators have shown
the GAS to be highly accurate in predicting mortality
(AUC 0.800).10,11 However the Dutch study showed
that none of the components of the GAS were independent
predictors of mortality (all P  .05). The average GAS for
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Fig 2. Observed vs expected 30-day mortality using t
expected mortality rate. There was no significant differ
patients of GAS69 (n 40), medium-risk patients with
77 (n  179).this group was 73. SThe GAS was a moderately accurate predictor of long-
erm death when applied to the open repair arm of the
utch Randomised Endovascular Aneurysm Management
DREAM) trial (AUC 0.740). ThemeanGASwas low in
his group (74.7; SD, 9.3), and the proposed cutoff point
etween high-risk and low-risk patients was only 75.5.12
he GAS was recently compared with more recent models
nd performed relatively poorly, despite an acceptable
UC of 0.749 (P  .01).13
The simplicity of the GAS remains a great strength,
aking it easier to use than any other system. It has been
alidated successfully previously and predicts in-hospital
ortality with acceptable accuracy in historical cohorts of
atients undergoing open AAA repair. A drawback of the
AS is that it does not reliably identify individual high-risk
atients due to a low-positive predictive value. It is also
naccurate when used to predict morbidity.
In our current study, we have shown that the GAS may
ot be valid when used to predict 30-day mortality after
pen aneurysm repair in the era of endovascular repair.
here are a number of possible explanations for this. The
AS is representative of preoperative physiologic reserve
ased on the burden of comorbidity present. Traditionally,
his has been the mainstay of preoperative assessment for
ajor abdominal and thoracic surgery. Factors that are not
ncorporated in the GAS may be important when predict-
ng death after open repair. Composite measures of fitness,
uch as measurement of preoperative anaerobic threshold,
ay provide a more dynamic measure of preoperative phys-
ology, but there are limited data to support this at pres-
nt.14
It is possible that as EVAR becomes the first-line treat-
ent for AAAs, those who undergo open repair are more
ikely to have complex or adverse aneurysm morphology.
AS
Observed Mortality
Expected Mortality
14
16.6
>77
nnvasc Glasgow Aneurysm Score validation tertiles as
between observed and expected mortality for low-risk
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of patients not deemed suitable for EVARmay determining
outcome. For example, adverse neck anatomy increases the
risk of early operative reoperation in open repair of AAAs
with complex neck anatomy.15 In a study examining the
late failure of open AAA repair, several factors were impor-
tant, including family history of aneurysmal disease, aneu-
rysms in other segments of the aorta, and other manifesta-
tion of atherosclerotic disease.16 These factors may also
play a part in predicting early complications. It is also
possible that advances in perioperative care in the 16 years
since the original GAS study mean that patients with mul-
tiple comorbidities have a greater chance of surviving sur-
gery.
A drawback of our study is that some potentially im-
portant information was not available to us, including the
reason for open repair rather than EVAR and exact cause of
death in each individual was not known. Knowing this
might have helped determine the reason for the higher
death rate in the nonsurvival group. The reason why pa-
tients were not treated by EVARwas not known either, and
there was no information regarding aneurysmmorphology.
Our cohort of patients had a higher average GAS than
those reported in other series, so it could that our group
represents a high-risk subgroup of all patients undergoing
AAA surgery. Despite this, the intraoperative mortality rate
of 5.4% reported in our study was not higher than average.
GAS possibly overestimated the risk of death in the survival
group, or underestimated the risk of death in the nonsur-
vival group. The GAS was designed and validated using
patients who were fit to undergo open infrarenal AAA
repair in a period when this was the only treatment possible.
It is feasible that it is not discriminatory in a higher-risk
cohort or the specific population that are selected to un-
dergo open repair when EVAR is an option.
CONCLUSIONS
The GAS did not discriminate between survivors and
nonsurvivors after open AAA repair in this cohort. Univar-
iate analysis of the individual score components revealed
that there were no significant differences between the
groups, suggesting that the score does not capture the
critical predictive factors in open AAA repair. In the era of
endovascular surgery, it is possible that the GAS does not
predict the outcome of open AAA repair. An alternative
explanation is that patients with risk factors for poor out-
come from EVAR, such as adverse AAA morphology, are
being selected out for open repair. Further work examining
the characteristics of patients being turned down for EVAR
and subsequently undergoing open repair may be justified.
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